Primary information |
---|
ID | antitb_1335 |
Peptide Name | Dihydromycoplanecin A |
Sequence | R-N(CH3)-CH(CH-CH3-CH3)-CO-N(CH-C-CH2-CH3-C-CH)-CO-N(CH3)-CH-C)-NH-CH(CH2-CH-CH3-CH3)-CO-N-CH-C-CH3_C-CH)-CONH-CH(CH2-CH2-CH-CH3-CH3)-Co-N-CH3-Ch-CH(CH3-CH3)-Co-N-(CH-C-Ch)-Co-N(CH3)-CH(CH2-CH-CH3-CH3)-CO-NH-CH2-CO-O-CH(CH3) |
N-terminal Modification | Propanol is attached |
C-terminal Modification | Free |
Chemical Modification | R =CH3-CH2-CH(OH)-CO |
Linear/ Cyclic | Cyclic |
Length | 21 |
Chirality | Mix |
Nature | NA |
Source | Natural |
Origin | Aspergillus awajinensis |
Species | Mycobacterium tuberculosis |
Strain | Mycobacterium tuberculosis H37Rv |
Inhibition Concentartion | IC50 = <0.0125 μg/mL (50%) |
In vitro/In vivo | Both |
Cell Line | NA |
Inhibition Concentartion | NA |
Cytotoxicity | NA |
In vivo Model | ICR/JCL male mice and male beagle dogs |
Lethal Dose | 10 mg/kg for mice and 50mg/kg for dog |
Immune Response | NA |
Mechanism of Action | NA |
Target | NA |
Combination Therapy | NA |
Other Activities | NA |
Pubmed ID | 3348603 |
Year of Publication | 1988 |
3-D Structure | NA |